These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35743736)

  • 1. Cost-Utility Analysis of Dupilumab for the Treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in Italy.
    De Corso E; Furneri G; Salsi D; Fanelli F; Ronci G; Sala G; Bitonti R; Cuda D
    J Pers Med; 2022 Jun; 12(6):. PubMed ID: 35743736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost Utility Analysis of Dupilumab Versus Endoscopic Sinus Surgery for Chronic Rhinosinusitis With Nasal Polyps.
    Scangas GA; Wu AW; Ting JY; Metson R; Walgama E; Shrime MG; Higgins TS
    Laryngoscope; 2021 Jan; 131(1):E26-E33. PubMed ID: 32243622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-utility analysis of dupilumab compared with endoscopic sinus surgery in patients with chronic rhinosinusitis with nasal polyps. Evaluation in Colombia, a developing country.
    Alvarez L; Querubin J; Bedoya J; Mejia A; Sánchez J
    Expert Rev Pharmacoecon Outcomes Res; 2023 Jun; 23(5):571-578. PubMed ID: 36976904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.
    Bachert C; Han JK; Desrosiers M; Hellings PW; Amin N; Lee SE; Mullol J; Greos LS; Bosso JV; Laidlaw TM; Cervin AU; Maspero JF; Hopkins C; Olze H; Canonica GW; Paggiaro P; Cho SH; Fokkens WJ; Fujieda S; Zhang M; Lu X; Fan C; Draikiwicz S; Kamat SA; Khan A; Pirozzi G; Patel N; Graham NMH; Ruddy M; Staudinger H; Weinreich D; Stahl N; Yancopoulos GD; Mannent LP
    Lancet; 2019 Nov; 394(10209):1638-1650. PubMed ID: 31543428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Effectiveness and Net Monetary Benefit of Olaparib Maintenance Therapy Versus No Maintenance Therapy After First-line Platinum-based Chemotherapy in Newly Diagnosed Advanced BRCA1/2-mutated Ovarian Cancer in the Italian National Health Service.
    Armeni P; Borsoi L; Fornaro G; Jommi C; Colombo N; Costa F
    Clin Ther; 2020 Jul; 42(7):1192-1209.e12. PubMed ID: 32591103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of biologics for the treatment of chronic rhinosinusitis with nasal polyps in Canada.
    Yong M; Kirubalingam K; Desrosiers MY; Kilty SJ; Thamboo A
    Allergy Asthma Clin Immunol; 2023 Oct; 19(1):90. PubMed ID: 37838713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of frontal sinusotomy for chronic rhinosinusitis with nasal polyps-A cost utility analysis.
    Scangas GA; Lehmann AE; Remenschneider AK; Su BM; Shrime MG; Metson R
    Laryngoscope; 2018 Jan; 128(1):43-51. PubMed ID: 28815611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness analysis comparing dupilumab and aspirin desensitization therapy for chronic rhinosinusitis with nasal polyposis in aspirin-exacerbated respiratory disease.
    Yong M; Wu YQ; Howlett J; Ballreich J; Walgama E; Thamboo A
    Int Forum Allergy Rhinol; 2021 Dec; 11(12):1626-1636. PubMed ID: 34309219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Utility Analysis of Maintenance Pemetrexed Plus Best Supportive Care Compared With Best Supportive Care Alone in Treating Patients With Non-Small Cell Lung Cancer in Jordan.
    Al Rabayah A; Al Froukh R; Sawalha R; Al Shnekat M; Jahn B; Siebert U; Jaddoua SM
    Value Health Reg Issues; 2024 Jun; 43():101004. PubMed ID: 38935989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma.
    Laidlaw TM; Bachert C; Amin N; Desrosiers M; Hellings PW; Mullol J; Maspero JF; Gevaert P; Zhang M; Mao X; Khan AH; Kamat S; Patel N; Graham NMH; Ruddy M; Staudinger H; Mannent LP
    Ann Allergy Asthma Immunol; 2021 May; 126(5):584-592.e1. PubMed ID: 33465455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost utility analysis of endoscopic sinus surgery for chronic rhinosinusitis with and without nasal polyposis.
    Scangas GA; Remenschneider AK; Su BM; Shrime MG; Metson R
    Laryngoscope; 2017 Jan; 127(1):29-37. PubMed ID: 27440486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-utility analysis of trabecular micro-bypass stents (TBS) in patients with mild-to-moderate open-angle Glaucoma in Italy.
    Fea AM; Cattel F; Gandolfi S; Buseghin G; Furneri G; Costagliola C
    BMC Health Serv Res; 2021 Aug; 21(1):824. PubMed ID: 34399759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps.
    Hopkins C; Wagenmann M; Bachert C; Desrosiers M; Han JK; Hellings PW; Lee SE; Msihid J; Radwan A; Rowe P; Amin N; Deniz Y; Ortiz B; Mannent LP; Rout R
    Int Forum Allergy Rhinol; 2021 Jul; 11(7):1087-1101. PubMed ID: 33611847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid and Continuing Improvements in Nasal Symptoms with Dupilumab in Patients with Severe CRSwNP.
    Bachert C; Khan AH; Hopkins C; Blaiss MS; Soler ZM; Nash S; Siddiqui S; Praestgaard A; Deniz Y; Rowe PJ; Jacob-Nara JA
    J Asthma Allergy; 2022; 15():557-563. PubMed ID: 35548056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Treatment in HCV: Is it a Cost-Utility Option from the Italian Perspective?
    Marcellusi A; Viti R; Damele F; Cammà C; Taliani G; Mennini FS
    Clin Drug Investig; 2016 Aug; 36(8):661-72. PubMed ID: 27234943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness Analysis of Nefecon versus Best Supportive Care for People with Immunoglobulin A Nephropathy (IgAN) in the United States.
    Ramjee L; Vurgun N; Ngai C; Patel M; Tremblay G
    Clinicoecon Outcomes Res; 2023; 15():213-226. PubMed ID: 37020570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dupilumab Reduces Asthma Disease Burden and Recurrent SCS Use in Patients with CRSwNP and Coexisting Asthma.
    Gurnell M; Radwan A; Bachert C; Lugogo N; Cho SH; Nash S; Zhang H; Khan AH; Jacob-Nara JA; Rowe PJ; Deniz Y
    J Asthma Allergy; 2024; 17():1-8. PubMed ID: 38250137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-utility analysis of dupilumab add on therapy versus standard therapy in adolescents and adults for severe asthma in Colombia.
    Antonio Buendía J; Patiño DG
    Expert Rev Pharmacoecon Outcomes Res; 2022 Jun; 22(4):575-580. PubMed ID: 34860616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of asthma on the cost effectiveness of surgery for chronic rhinosinusitis with nasal polyps.
    Scangas GA; Remenschneider AK; Su BM; Shrime MG; Metson R
    Int Forum Allergy Rhinol; 2017 Nov; 7(11):1035-1044. PubMed ID: 28873286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dupilumab reduces systemic corticosteroid use and sinonasal surgery rate in CRSwNP.
    Desrosiers M; Mannent LP; Amin N; Canonica GW; Hellings PW; Gevaert P; Mullol J; Lee SE; Fujieda S; Han JK; Hopkins C; Fokkens W; Jankowski R; Cho SH; Mao X; Zhang M; Rice MS; Khan AH; Kamat S; Patel N; Graham NMH; Ruddy M; Bachert C
    Rhinology; 2021 Jun; 59(3):301-311. PubMed ID: 33847325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.